Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia (Q44298792)

1 December 2017

Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia (English)

1 reference

1 December 2017

0 references

0 references

Giuseppe Danilo Norata

5

1 reference

1 December 2017

6

1 reference

1 December 2017

7

1 reference

1 December 2017

Liliana Grigore

1

1 reference

1 December 2017

Sara Raselli

2

1 reference

1 December 2017

Katia Garlaschelli

3

1 reference

1 December 2017

Laura Redaelli

4

1 reference

1 December 2017

10 July 2012

1 reference

European Journal of Clinical Pharmacology

1 December 2017

1 reference

1 December 2017

69

1 reference

1 December 2017

3

1 reference

1 December 2017

341-346

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-012-1345-z

1 December 2017

0 references

cites work

Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

21 January 2018

Endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Recent advances in understanding endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Cellular antioxidant effects of atorvastatin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Ezetimibe: the first in a novel class of selective cholesterol-absorption inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Non-invasive assessment of endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Lipoprotein remnants and endothelial dysfunction in the postprandial phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Statin therapy for vascular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Short- and long-term changes of flow-mediated vasodilation in patients under statin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Recommendations for the use of LDL apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Statin-induced myopathy: a review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

The safety of statins in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1345-Z

The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers

21 January 2018

1 reference

12 December 2020

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

12 December 2020

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

12 December 2020

HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease

1 reference

12 December 2020

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

12 December 2020

The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients

1 reference

12 December 2020

New evidence for beneficial effects of statins unrelated to lipid lowering

1 reference

12 December 2020

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

12 December 2020

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

12 December 2020

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

1 reference

12 December 2020

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

12 December 2020

Beneficial cardiovascular pleiotropic effects of statins

1 reference

12 December 2020

Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase

1 reference

12 December 2020

10.1007/S00228-012-1345-Z

Identifiers

DOI

1 reference

1 December 2017

1 reference